To knock down the following myths: obesity in paediatric patients is rare and mainly a North-American problem; obesity in childhood has no long-term harmful effects. To sensitize the anaesthesiologists to a problem seldom addressed in the anaesthetic literature.
Introduction
A worldwide increase in the prevalence of obesity has been observed recently in both developed and developing countries [1] . For example, the annual absolute changes in the prevalence of obesity in children between 1985 and 2004 are estimated to be 1.7% in Australia, 0.8% in the US, 0.5% in the UK, 0.5% in China and 0.4% in Brazil [2] . In western Europe, 15-20% of children and adolescents are obese. The idiom 'pandemia of the new millennium' is used in the paediatric and obesity literature. Moreover, children who are overweight are more likely to continue to gain weight and to become overweight or obese adolescents and obese adults. Last, they already present with manifestations of the comorbidities associated with adult obesity.
Little anaesthetic literature has been devoted so far to this topic, and most data are inferred from what is known about the anaesthetic management of obese adults [3] [4] [5] . From the anaesthesiologist's point of view, caring for an obese child or adolescent means dealing with early manifestations of the comorbidities of adult obesity and sometimes for new surgical procedures (bariatric surgery).
Definitions
The body mass index (BMI ¼ kg Â m À2 ) is used to quantify overweight in adults: a BMI of 25 or more means overweight; 30 or more, obesity; and 40 or more, morbid obesity. BMI, however, cannot be used as such in paediatric patients because of growth and differences in the distribution of fat and muscles, body shape or bone density occurring at puberty. Therefore, specific growth curves showing the percentiles for BMI according to age and sex have been established [3, 5] .
Two sets of curves are used. The first uses representative data from the US (website: www.cdc.gov/nchs/data/ nhanes/growthcharts/set3chart%2016.pdf) and according to it (1) a BMI of more than percentile 85 of the BMI at the child's age means overweight; (2) a BMI of more than percentile 95 means obesity;
(3) a BMI of more than percentile 99 means super obesity.
The second aims more at defining internationally valid cut-off points for BMI by extrapolating down to childhood the curves corresponding to a BMI of 25 or 30 at 18 years of age [6] . The results are somewhat different; for example, a boy is obese if his BMI is over 19.5 vs. 20.6 at 7 years of age or over 25.5 vs. 27.6 at 14 years.
The following definitions are often referred to in the literature:
( 
Causes of obesity
In over 90% of the cases, overweight and obesity are caused by the combination of consuming too many calories (increased fat content in foods, high calorie drinks) and not having enough physical activities (watching TV). Environmental and genetic factors (leptin deficiency) probably play a minor role, but in rich countries, obesity is usually more prevalent in lower income social categories [3, 5] .
In approximately 5% of the cases, however, a medical cause of obesity can be identified as (1) a syndrome: Prader-Willi syndrome beyond infancy, Laurence-Moon-Biedl syndrome (2) some inborn errors of metabolism necessitating a hypercaloric diet to prevent hypoglycaemia (e.g. glycogen storage diseases) or protein catabolism (3) iatrogenicity: high-dose steroid therapy such as in paediatric haematology and oncology, nephrotic syndrome and others (4) or inability to move, for example, late stage Duchenne's muscular dystrophy.
Pathophysiology
Adipose tissue has for long been considered as a passive stocking area for fat [7] . It is presently known to be a complex endocrine system communicating with the brain and peripheral tissues by releasing leptin and adipokynins proteins such as C-reactive protein (CRP), interleukin (IL)-6, tumour necrosis factor a (TNFa), lipoproteinlipase , renin, adiponectin, etc. Its malfunction leads first to resistance to insulin and then to the metabolic syndrome (i.e. central obesity, hyperinsulinaemia, systemic hypertension and hypertriglyceridaemia). Obesity can, in fact, be considered as a chronic inflammatory state.
Obese paediatric patients show the following early manifestations of the comorbidities found in adult obesity.
Respiratory
The incidence of asthma, especially exercise-induced asthma, is increased and is prevalent in up to 30% of overweight children [3, 5] . In case of obesity, a restrictive pattern is also present; chest wall compliance decreases along with functional residual capacity (FRC), vital capacity and inspiratory capacity. This increases the work of breathing and the risk of atelectasis as the lung closing volume falls within tidal ventilation, further leading to chronic hypoxemia in case of severe obesity.
Sleep apnoea disorders (i.e. recurrent episodes of partial or complete airway obstruction during sleep) are present in at least 17% of obese children. Both increased visceral fat favouring airway collapse and increased pharyngeal fat decreasing the upper airway caliber contribute to it. Obstructive sleep apnoea induces chronic nocturnal hypoxaemia and leads progressively to pulmonary hypertension and cor pulmonale. Moreover, daytime sleepiness increases physical inactivity.
Cardiovascular
The prevalence of systemic hypertension increases with BMI. Obese children have an increased heart rate (HR) and blood pressure (BP) because their sympathetic nervous system is overactive. Moreover, as adipose tissue is well vascularized, an increased cardiac output (grossly 0.1l/min for each kg of excess adipose tissue) and blood volume is observed. As a consequence, left ventricular (LV) hypertrophy develops early but is reversible with weight loss. In severely obese adolescents, increased oxygen consumption increases the workload of the heart and they are at risk of myocardial strain.
Endocrine
Resistance to insulin and the metabolic syndrome is present in 39% of moderately obese and in 50% of severely obese adolescents [8] . CRP and IL-6 levels rise with the degree of obesity, whereas those of adiponectin, a biomarker of insulin insensivity, decrease. These proteins are also potential predictors of adverse cardiovascular effects caused by atheromatosis. Diabetes type 2 develops rapidly once the metabolic syndrome is present.
Gastrointestinal
Due to the increased abdominal mass, gastroesophageal reflux disease is frequent. Regarding gastric emptying time, studies show conflicting results; some show a delayed gastric emptying time whereas others show no difference as compared with nonobese patients.
Nonalcoholic fatty liver disease (NAFLD) is present in 50-60% of obese children [3, 9] and is probably the most common form of chronic liver disease in children in the US. Histologically, it progresses from hepatic steatosis (abnormal accumulation of fat in hepatocytes) to fibrosis. Due to unknown genetic and/or environmental risk factors, nonalcoholic acute steatohepatitis (NASH) can also occur, and a few cases of cirrhosis have been described. NAFLD is often asymptomatic; increased serum alanine aminotransferase (ALT) is present only in severe cases, and ultrasound examination is the most reliable way to screen it. Both steatosis and NASH may get resolved with weight reduction.
Psychology
Some form of depression with a poor body image and loss of self-esteem are often present in obese paediatric patients. The relationship with lean peers is poor (teasing, marginalization).
Some pathologies specific to the paediatric age group are (1) slipped capital femoral epiphysis;
(2) tibia vara (Blount disease): repetitive trauma from overweight on the medial tibial growth plate results in growth plate suppression and varus deformity of the tibia; (3) cholelithiasis, because bile is supersaturated with cholesterol; (4) polycystic ovary syndrome with clinical signs of hyperandrogenism (hirsutism, irregular menses); (5) idiopathic intracranial hypertension (pseudotumour cerebri), probably caused by increased intrathoracic pressure, decreasing venous outflow from the head.
Pharmacology
The adequate dosage of anaesthetic drugs is difficult to guess in an obese patient; theoretically, lipophilic drugs have an increased volume of distribution, and the pharmacology of hydrophilic drugs remains unchanged. Literature on adults, however, shows that it is not always true and there are conflicting results [3, 10] . Moreover, little is known about protein binding and metabolization, although renal clearance is generally increased.
As a rule of thumb, the initial dose should be calculated according to the patient's IBW, and titrated to effect. Regarding thiopental and midazolam, the distribution volume of which is increased in obese adults, an increased duration of action should be expected if dosage is made according to TBW. The dosage of succinylcholine should be calculated according to TBW. If sevoflurane is used, an increased production of F-is observed but no nephrotoxicity has been reported. Desflurane is considered the best choice for maintenance in obese patients.
Medical and surgical treatment of obesity
As behavioural weight management alone is poorly effective in managing severe overweight or obesity, medical or surgical treatments are often proposed.
Medical treatment
The following drugs are sometimes prescribed to obtain some weight loss:
(1) Orlistat decreases the bowel absorption of triglycerides present in food by 30%. (2) Sibutramine has an anorexigen effect by inhibiting the reuptake of noradrenalin and serotonin; drug interactions are thus possible (e.g. with tramadol). (3) Rimonabant blocks the cellular cannabinoid receptor 1 in the brain, bowel and adipose tissue. Its use in paediatric patients is not allowed by the Food and Drug Administration (FDA). (4) Metformin is used in case of diabetes type 2.
Bariatric surgery
As medical treatment often fails, surgery is increasingly proposed to produce weight loss because it may reverse the metabolic and psychosocial consequences of obesity in adolescence [5, 11 ] .
Two main types of procedures exist: 
Anaesthetic management
Most data on the perianaesthetic care of obese paediatric patients are inferred from the literature on the anaesthetic management of obese adults [3] [4] [5] . They are summarized hereafter.
Preoperative examination
A careful history should be taken regarding (1) symptoms of sleep apnoea: snoring, bad sleep with frequent awakening, day-time sleepiness; (2) tolerance to exercise: breathlessness, asthma;
(3) recent weight loss or gain; (4) medications, including herbs or special mixtures, taken to lose weight which can interfere with anaesthesia or haemostasis.
In addition to the standard physical examination done before any anaesthesia, a BMI percentile chart should be used to know whether the patient is overweight or obese. In case of obesity, transcutaneous haemoglobin saturation (SpO 2 ) during breathing room air should be documented, and fasting blood glucose, night oximetry (if symptoms of sleep apnoea) and echocardiography (if hypertension is present) should be checked.
The same rules for preoperative fasting should be applied as in the nonobese population. In case of gastroesophageal reflux disease, the patient's usual antireflux therapy should be administered.
Induction and maintenance
Room air SpO 2 should be checked again in order to obtain an individualized target value for postoperative values. Difficult venous access should be foreseen. Inhalation induction is possible but is often longer and difficult due to ventilation-perfusion (V/Q) mismatch, intermittent airway obstruction and difficult mask fit.
Controlled ventilation via a tracheal tube is the best way to protect the airway and provide adequate ventilation; no data have been published so far on the use of the Proseal LMA (LMA Deutschland GmbH, Bonn, Germany) in obese patients but it remains a safe option in case of difficult intubation-difficult ventilation situation.
In order to lessen the risk of hypoxaemia during apnoea, careful preoxygenation should be undertaken; a 258 headup position makes breathing easier and reduces abdominal pressure on the diaphragm, and at least 3 min of tidal breathing with 100% oxygen is necessary [3] . The best way to check adequacy of preoxygenation is to obtain an end-tidal oxygen concentration of more than 90% [12 ] . Whether rapid sequence induction (RSI) is mandatory in elective cases is a controversial issue, and many teams do not use it (or use a modified RSI) on the basis of a lack of evidence base of its usefulness [13 ] . It should, however, be kept in mind that both mask ventilation and intubation can be difficult, and that gastric inflation increases the risk of regurgitation.
Adequate equipment should be used to measure the BP. In case of invasive surgery, it is worth inserting an arterial catheter to measure it precisely and to be able to check blood gases.
Due to the V/Q mismatch, E T CO 2 is not very reliable to evaluated PaCO 2 ; either blood gases or a transcutaneous measure of PaCO 2 (e.g. Tosca, Linde Medical Sensors AG, Basel, Switzerland) [14] can be used. Controlled ventilation with some positive end expiratory pressure (PEEP) is useful to catch up some FRC and prevent atelectasis, but excessive PEEP is poorly tolerated from the haemodynamic point of view.
If the patient is operated upon in the supine position, a head-up positioning (25-308) should be obtained from the surgeon to improve ventilation; the head-down position is often poorly tolerated.
Emergence and postoperative care
The patient should be extubated awake and in a head-up position. Some continuous positive airway pressure (CPAP) should be provided in the postanaesthesia care unit (PACU) as well as in the ward later. Although no firm recommendations have been published, there is an increased risk of peripheral venous thrombosis, and thromboprophylaxis should be prescribed.
Pain management
If intravenous patient-controlled analgesia is used, the initial dosage of morphine should be calculated according to IBW and reduced further by 25%. It should be adapted later according to the patient's response.
Regarding locoregional anaesthesia, the volume of the epidural space is probably reduced because of increased intraabdominal pressure and possibly because of increased venous return through Batson's plexus; the initial volume of locoregional anaesthesia to be administred epidurally should be calculated according to LBW.
Anaesthetic morbidity
Two retrospective series have been published so far. In 100 obese children out of a series of 1133 children less than 12 years of age undergoing outpatient dental procedures, the obese children had a higher incidence of intraoperative desaturation (SpO 2 <85%) (2% vs. 0.19%) and unexpected overnight hospitalization because of postoperative desaturation than nonobese children [15] .
In another series of 6094 patients [16 ] (mean age, 11.9 AE 5.2 years) out of whom 14.4 and 17.2% were overweight and obese, respectively, (1) the prevalence of diabetes type 2, hypertension and asthma was higher in obese and overweight patients than in their nonoverweight peers; (2) difficult airway and laryngoscopy was more common in obese children; (3) obese and overweight patients stayed longer in the PACU because of upper airway obstruction.
These data suggest that, although rare, perioperative respiratory events are more frequent in overweight and Child obesity and anaesthetic morbidity Veyckemans 311 obese patients; prospective studies are needed to confirm it.
Conclusion
Obesity is not rare in paediatric patients and we should introduce the use of BMI charts in our preoperative assessment to identify such patients and adapt our perioperative management accordingly. In obese children, perioperative morbidity is mainly related to airway and ventilation.
